Cite
HARVARD Citation
Du, S. et al. (2014). SAT0210 X-Ray and MRI Results from A Phase Iib Study of Subcutaneous Anti-Interleukin-6 Monoclonal Antibody Clazakizumab with or without MTX in Adults with Moderate-To-Severe Active RA and Inadequate Response to Conventional DMARDS Including Methotrexate. Annals of the rheumatic diseases. pp. 665-666. [Online].